🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, asserting the firms concealed potential risks that the drug presented to children's brain development.

The lawsuit follows a month after Former President Trump publicized an unsubstantiated connection between taking acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against Johnson & Johnson, which previously sold the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he claimed they "betrayed America by making money from suffering and marketing drugs without regard for the potential hazards."

Kenvue states there is lacking scientific proof linking acetaminophen to autism.

"These corporations deceived for years, intentionally threatening countless individuals to increase profits," Paxton, a Republican, declared.

The manufacturer commented that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its online platform, the company also mentioned it had "regularly reviewed the applicable studies and there is insufficient valid information that shows a verified association between consuming paracetamol and autism."

Groups speaking for doctors and health professionals agree.

ACOG has said acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and fever, which can create serious health risks if left untreated.

"In over twenty years of studies on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any period of pregnancy causes neurological conditions in children," the association stated.

The court filing mentions current declarations from the former administration in arguing the medication is reportedly hazardous.

Recently, Trump raised alarms from health experts when he told expectant mothers to "fight like hell" not to consume acetaminophen when ill.

Federal regulators then issued a notice that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had pledged in April to undertake "comprehensive study program" that would establish the cause of autism in a short period.

But specialists advised that identifying a sole reason of autism - thought by researchers to be the consequence of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that influences how persons experience and relate to the environment, and is identified using doctors' observations.

In his lawsuit, Paxton - a Trump ally who is campaigning for federal office - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the science" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the firms "destroy any commercial messaging" that claims Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the grievances of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in two years ago.

The court dismissed the legal action, stating investigations from the plaintiffs' authorities was not conclusive.